Lv1
18 积分 2024-12-24 加入
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
3天前
已完结
A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
20天前
已完结
Improving early phase oncology clinical trial design: A case study
28天前
已完结
ASBMT Consensus Grading for Cytokine Release Syndrome and Neurological Toxicity Associated with Immune Effector Cells
1个月前
已完结
Risk factors for CAR-T cell manufacturing failure among DLBCL patients: A nationwide survey in Japan
2个月前
已完结
Recent Bendamustine Treatment Before Apheresis Has a Negative Impact on Outcomes in Patients With Large B-Cell Lymphoma Receiving Chimeric Antigen Receptor T-Cell Therapy
2个月前
已完结
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
3个月前
已完结
Backfilling Patients in Phase I Dose-Escalation Trials Using Bayesian Optimal Interval Design (BOIN)
4个月前
已完结
Cytokines in cancer
4个月前
已完结
皖公网安备34019202002308
